Algeria vs Nicaragua: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Algeria
- Nicaragua
How they compare
Algeria currently reports 13.3% against 12.6% in Nicaragua, a difference of 0.7%.
That makes Algeria's figure about 1.1 times Nicaragua's.
Across all 22 years both countries report, Algeria has been ahead every year.
Algeria ranks 139th and Nicaragua ranks 142nd of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.9% | 14.1% | 2.8% | Algeria |
| 2010s | 14.4% | 13.5% | 0.9% | Algeria |
| 2020s | 13.0% | 12.5% | 0.5% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Algeria or Nicaragua?
- Algeria, at 13.3% against 12.6% in Nicaragua as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Algeria and Nicaragua?
- 0.7%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Nicaragua?
- 22 years are reported by both, from 2000 to 2021.
- How do Algeria and Nicaragua rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Algeria ranks 139th and Nicaragua ranks 142nd of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).